Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02363439 · OUTCOME

Number of Participants With Adverse Events

Extension Study of IMO-8400 in Patients With Waldenström's Macroglobulinemia Who Completed Study 8400-401 · Source last updated 2018-01-09

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
During receipt of study treatment on the trial.

What was measured

Long term safety and tolerability of IMO-8400 in patients with Waldenstrom's Macroglobulinemia

Analysis population: Safety population

Groups in this outcome

IMO-8400 0.6 mg/kg/wk or 1.2 mg/kg 2xwk

Subcutaneous injection of IMO-8400 0.6 mg/kg/wk or 1.2 mg/kg twice weekly per Protocol 8400-401

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
IMO-8400 0.6 mg/kg/wk or 1.2 mg/kg 2xwk5

Reported measurements

Source class 1
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
IMO-8400 0.6 mg/kg/wk or 1.2 mg/kg 2xwk4Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        4
denoms
  1. counts
    1. group Id
      OG000
      value
      5
    units
    Participants
description
Long term safety and tolerability of IMO-8400 in patients with Waldenstrom's Macroglobulinemia
groups
  1. description
    Subcutaneous injection of IMO-8400 0.6 mg/kg/wk or 1.2 mg/kg twice weekly per Protocol 8400-401
    id
    OG000
    title
    IMO-8400 0.6 mg/kg/wk or 1.2 mg/kg 2xwk
param Type
COUNT_OF_PARTICIPANTS
population Description
Safety population
reporting Status
POSTED
time Frame
During receipt of study treatment on the trial.
title
Number of Participants With Adverse Events
type
PRIMARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice